To provide the potential for reliable growth by tracking the performance of the FTSE All-Share Index*.
Name | % Net Assets |
---|---|
BP PLC | 6.9% |
HSBC Holdings PLC | 6.7% |
Vodafone Group PLC | 4.8% |
GlaxoSmithKline PLC | 4.3% |
Royal Dutch Shell PLC | 4.2% |
Royal Dutch Shell PLC B | 3.2% |
AstraZeneca PLC | 3.0% |
BG Group PLC | 2.7% |
British American Tobacco PLC | 2.6% |
BHP Billiton PLC | 2.3% |
Key | % Net Assets |
---|---|
BP PLC | 6.9% |
HSBC Holdings PLC | 6.7% |
Vodafone Group PLC | 4.8% |
GlaxoSmithKline PLC | 4.3% |
Other | 77.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 175.40p |
Currency | GBP |
Change | 0.60p |
% | 0.34% |
YTD change | 7.90p |
YTD % | 4.72% |
Fund Inception | 24/09/1992 |
---|---|
Fund Manager | Ian Clarke |
TER | 0.56 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.40% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research